Infection risk in Rheumatoid Arthritis and Spondyloarthropathy patients under treatment with DMARDs, Corticosteroids and TNF-α antagonists

被引：0
|
作者：
Valentina Germano
Maria Sofia Cattaruzza
John Osborn
Aurora Tarantino
Roberta Di Rosa
Simonetta Salemi
Raffaele D’Amelio
机构：
[1] “Sapienza” University of Rome,Department of Clinical and Molecular Medicine
[2] S. Andrea University Hospital,Department of Public Health and Infectious Diseases
[3] “Sapienza” University of Rome,undefined
[4] Italian Air Force,undefined
[5] Logistic Command,undefined
[6] Health Service,undefined
来源：
Journal of Translational Medicine | / 12卷
关键词：
Rheumatoid Arthritis; Spondyloarthropathy; Infection risk; anti-TNFα; DMARDs; Corticosteroids;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Infection risk in Rheumatoid Arthritis and Spondyloarthropathy patients under treatment with DMARDs, Corticosteroids and TNF-α antagonists
    Germano, Valentina
    Cattaruzza, Maria Sofia
    Osborn, John
    Tarantino, Aurora
    Di Rosa, Roberta
    Salemi, Simonetta
    D'Amelio, Raffaele
    JOURNAL OF TRANSLATIONAL MEDICINE, 2014, 12
  • [2] Serious infections under treatment with TNF-α antagonists compared to traditional DMARDs in patients with rheumatoid arthritis
    N. Inanc
    H. Direskeneli
    Rheumatology International, 2006, 27 : 67 - 71
  • [3] Serious infections under treatment with TNF-α antagonists compared to traditional DMARDs in patients with rheumatoid arthritis
    Inanc, N.
    Direskeneli, H.
    RHEUMATOLOGY INTERNATIONAL, 2006, 27 (01) : 67 - 71
  • [4] Cardiovascular Risk in Rheumatoid Arthritis: Comparing TNF-α Blockade with Nonbiologic DMARDs
    Solomon, Daniel H.
    Curtis, Jeffrey R.
    Saag, Kenneth G.
    Lii, Joyce
    Chen, Lang
    Harrold, Leslie R.
    Herrinton, Lisa J.
    Graham, David J.
    Kowal, Mary K.
    Kuriya, Bindee
    Liu, Liyan
    Griffin, Marie R.
    Lewis, James D.
    Rassen, Jeremy A.
    AMERICAN JOURNAL OF MEDICINE, 2013, 126 (08): : 730.e9 - 730.e17
  • [5] TNF-α Antagonists and Other Recombinant Proteins for the Treatment of Rheumatoid Arthritis
    Brasington, Richard
    JOURNAL OF HAND SURGERY-AMERICAN VOLUME, 2009, 34A (02): : 349 - 350
  • [6] CIDP Induced by TNF-α Antagonists in Rheumatoid Arthritis
    Miles, J. Douglas
    Basiri, Keivan
    Katirji, Bashar
    Alshekhlee, Amer
    NEUROLOGY, 2009, 72 (11) : A364 - A364
  • [7] Plasmapheresis therapy in combination with TNF-α inhibitor and DMARDs: A multitarget method for the treatment of rheumatoid arthritis
    Cheng, Yongjing
    Yang, Feng
    Huang, Cibo
    Huang, Jia
    Wang, Qian
    Chen, Yingjuan
    Du, Yingjue
    Zhao, Like
    Gao, Ming
    Wang, Fang
    MODERN RHEUMATOLOGY, 2017, 27 (04) : 576 - 581
  • [8] Risk of Malignancy with TNF-α Inhibitors in Patients with Rheumatoid Arthritis
    Khan, Omair
    Baqir, Syed Mujtaba
    Naeem, Azka
    Khan, Muhammad Hashim
    Shyam, Tharun
    Slobodyanyuk, Kseniya
    Slobodnick, Anastasia
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 2853 - 2856
  • [9] A systematic review of the effect of TNF-α antagonists on lipid profiles in patients with rheumatoid arthritis
    Eduardo Nicolas Pollono
    Maria A. Lopez-Olivo
    Juan Antonio Martinez Lopez
    Maria E. Suarez-Almazor
    Clinical Rheumatology, 2010, 29 : 947 - 955
  • [10] Safety of TNF-α antagonists in patients with rheumatoid arthritis and chronic hepatitis C.
    Peterson, CJR
    Wener, MH
    Hsu, FC
    Simkin, PA
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S78 - S78
12345